The aim of the study was to describe the clinical and epidemiological characteristics, anatomic and histologic distribution, and treatment results of extranodal lymphomas (ENLs), diagnosed and treated in the public health system in Chile. We included patients with ENL diagnosed from 1998 to 2014, in 17 cancer centers, registered prospectively in the database of the National Adult Cancer Program (PANDA) of the Ministry of Health. Treatment was based on the local protocols for each lymphoma subtype. Extranodal lymphoma was documented in 1215 of 4907 nonHodgkin lymphomas diagnosed in that period (25%). Median age was 59 years (range, 16-95), and 55% were female. The gastrointestinal (GI) tract was the most common location (38%), followed by the head and neck (24%) and the skin (15%).
| INTRODUCTION
The definition of extranodal lymphomas (ENLs) is still controversial.
Even though it generally includes those originating outside lymph nodes, spleen, thymus, and Waldeyer ring, this last site is considered extranodal in several published cohorts. [1] [2] [3] Extranodal lymphomas may arise virtually in all body tissues; they comprise around 30% of non-Hodgkin lymphomas (NHLs), and their incidence has increased over time. Diagnostic clinical stage is not straightforward, and it can be often difficult to differentiate stage IE from stage IV, eg, in the presence of bilateral involvement of paired organs with no other lesions. 4 The majority are diffuse large B-cell lymphomas (DLBCL). 5 Prognosis depends on histology, just like in nodal lymphomas. However, the primary organ of origin is the most significant prognostic factor, due to differences in the natural history of the disease and management strategies related to organ-specific problems. 2 For example, central nervous system (CNS) and testicle require specific interventions. 1, 2 We have no solid data available in Chile on this heterogeneous group of lymphomas.
In the present study, we evaluated the epidemiologic distribution of ENL taking into account the primary organ involved, histological subtypes, and survival of patients treated at public health hospitals in Chile with protocols of the National Adult Cancer Program (PANDA). 6 2 | PATIENTS AND METHODS
| Eligibility
We prospectively registered in a database all patients with NHL 
| Histopathology
The WHO 2008 classification of lymphoid neoplasms was used for histological classification. 8 Approximately 90% of cases were reviewed by the same pathologist (VM) on embedded paraffin tissue, and 5% of them were reclassified after the review. Immunohistochemistry was performed in all cases, using mainly the following markers: CD45, CD20, CD3, CD4, CD5, CD7, CD10, cyclin D1, bcl2, bcl6, kappa, lambda, CD56, ALK, and EBER.
| Treatment and follow-up
Treatment was administered according to the period when the diagno- 
| Statistical methods
Clinico-pathological characteristics were expressed in absolute numbers and percentages. The response to treatment was defined according to the Cheson 2007 criteria. 9 Overall survival (OS) was defined as the time from beginning of treatment until death from any cause and was estimated using the Kaplan Meier method; comparison between groups was made by log rank test. Progression free survival (PFS)
was not evaluated because the date of relapse or progression was not available in all patients. Cox proportional hazards model was used to evaluate independent factors affecting survival. P was considered significant if<0.05. Statistical analysis was performed using the STATA 14software package.
| RESULTS
A total of 4907 patients were diagnosed with NHL, and 1215 were ENL (24.8%). B-cell lymphomas comprised 78% (948 cases) of all ENL cases, and T-cell lymphomas comprised 22% (267 cases), being mycosis fungoides the most common (97 cases, 36%), followed by extranodal NK/T nasal-type lymphoma (65 cases, 24%).
Sixty-four percent (780/1215) of the cases were diagnosed at stage IE. Median age was 59 years old , and 55% were women.
Some organs had a significantly higher frequency in women, such as salivary glands and thyroid gland (80% and 79%, respectively).
The distribution by involved site is presented in Figure 1 . The most common site was GI 452/1215 (37%), followed by head and neck (H&N) lymphomas 290/1215 (24%). The skin was the third most common location 177/1215 (14.6%). The clinical characteristics according to involved site are presented in Table 1 .
FIGURE 1 Extranodal sites involved in non-Hodgkin lymphoma in
Chile. 1998 to 2014 (n = 1215 cases). Gastrointestinal (GI) tract includes stomach, small instestine, colon, and rectum; Waldeyer ring includes tonsil, palate, pharynx, and base of the tongue. CNS, central nervous sysytem
| Lymphoma subtypes
The B-and T-cell lymphoma subtypes are presented in Figure 2 .
Within the GI lymphoma, the stomach was the most common involved site (339 cases, 28%). The distribution within the rest of the GI tract is shown in Table 2 and the histology in Table 3 . The most common site of involvement in HIV-positive patients was GI 28/65 (43%), followed by paranasal sinuses and oral cavity (8 each, 24%) and CNS (8/65, 12%). More than half of the patients with rectal lymphoma (7/12, 58%) were HIV-positive, in contrast with only 5% in the full cohort of patients (65/1215).
B-cell lymphomas represented 93% (430/459) of the GI tract cases, mostly DLBCL. T-cell lymphomas were mostly located in small intestine (Table 3) . Notably, 76% (88/116) of MALT lymphomas were diagnosed in women.
The distribution within H&N was as follows: Waldeyer ring 9.3% The histologic subtype distribution of the main primary non-GI lymphoma sites is shown in Table 4 .
| Outcome
Median follow-up was 9.6 years. Figure 3 shows the OS of the main sites. The reported OS for H&N lymphoma at 5, 10, and 15 years 
FIGURE 2
Histologic subtypes of 948 cases of B-cell and 267 cases of T-cell extranodal lymphomas. Enteropathy-associated T-cell lymphoma 0.8%, angioimmunoblastic T-cell lymphoma 0.8%, subcutaneous panniculitis type 0.4%; ATLL, adult T-cell leukemia/ lymphoma; DLBC, diffuse large B-cell lymphoma was 63%, 50%, and 38%, respectively, with a median survival of 129 months. In the case of cutaneous lymphomas, the reported OS at 5, 10, and 15 years was 64%, 50%, and 36%, respectively, with a median follow-up of 121 months. The OS in the primary bone lymphoma was 59%, 55%, and 41%, respectively, with a median followup of 160 months. In the primary testis lymphomas, the OS was 65%, 39%, and 26%, respectively, with a median follow-up of 106 months, and in the primary CNS, it was 33%, 22%, and 0%, respectively, with a median follow-up of 25.6 months.
Overall survival in gastric DLBCL and MALT type at 5, 10, and 15 years was 70%, 50%, and 45% and 80%, 63%, and 59%, respectively (P = 0.04).
| DISCUSSION
Extranodal lymphomas are heterogeneous in their geographic distribution. In Chile, they constituted 24.8% of all NHLs, a similar proportion to that described in the United States but lower than other countries [10] [11] [12] [13] like Denmark (33%), Kuwait (43%), Japan (46%), Italy (48%), China (53%), or Thailand (55%). The reason for the higher proportion of ENL in Asia may be the higher frequency of extranodal NK/T lymphoma nasal type, Waldeyer ring, and skin involvement in those geographic areas.
We observed a significantly high incidence of NK/T cell nasaltype lymphoma in the Chilean population. This finding was not 15 For instance, in our series, as well as in a US study, 15 there was a higher prevalence of women with thyroid lymphoma, in concordance with Hashimoto's thyroiditis 17, 18 as well as other autoimmune disease such as Sjogren's syndrome and salivary gland lymphomas.
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Gastrointestinal tract was the most common extranodal site involved, although we found a slightly lower incidence than what is reported in the literature (28% vs 30-45%, respectively). 2, 20 The most frequent involved site was the stomach (74%), similar to that described in German cohorts [21] [22] [23] and as a former Chilean study (70%). 24 The next most common segment of GI involvement was small intestine (8.7%), colon (6.5%), and ileocecal region (4.3%). A Danish study showed higher rates in small intestine (16%) and lower in colon (3%).
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The H&N represents the second most common site in our series, and this is in keeping with the available literature. 26 In Asia, however, H&N is the most common site, due to a higher prevalence of sinonasal and Waldeyer ring NK/T-cell lymphomas. 12, 13 Cutaneous lymphomas were the third most common location. Also, in keeping with published reports, more than two thirds were T-cell lymphomas, and mycosis fungoides represented half of them. 27, 28 However, distinctly from European countries or United States, adult T-cell leukemia/lymphoma represented up to 6% of the T-cell lymphomas in a Chilean study. 29 Less common sites of lymphoma, like the CNS, showed a frequency (3.6%) similar to the literature (3-6%). However, the outcome was inferior, even though most of them received high-dose MTX, cytarabine, and radiotherapy, possibly because our protocols did not include MTX doses [30] [31] [32] higher than 2 g/m 2 .
The primary bone lymphoma presented a similar frequency [33] [34] [35] compared with that published (3.4%). Median survival in our population of patients was again lower, especially for those patients who did not receive immunochemotherapy.
With a 5-year OS of 63%, the primary testicular lymphoma showed a better outcome in our patients compared with the largest historical series. [36] [37] [38] However, these results are inferior to those (5-year OS, 85%) of the prospective IELSG10 study, which combined R-CHOP, intrathecal CNS prophylaxis, and contralateral testis irradiation.
Within the GI tract lymphomas, the predominant histology was DLBCL (60%), a prevalence slightly higher than the ones reported in the abovementioned German studies [21] [22] [23] and in a Canadian cohort. 39 In our study population, GI tract lymphoma appeared to affect women most frequently than men, which is different with most reports in the literature. In Chile, the male/female ratio was 0.9, while in China, India, Canada, and the United States, it was 2.9, 3.9, 1.5, and 1.7, respectively. [40] [41] [42] Interestingly, the same observation was made in another study from Peru, 43 suggesting that genetic/environmental characteristics may influence the gender distribution in Latin American countries.
As expected, histology (DLBCL vs MALT) affected the outcome. However, another peculiar feature in our cohort is the striking inferior long-term survival of gastric MALT lymphoma patients in comparison with the literature, with only 63% of our patients were alive 44-46 at 10 years. Unfortunately, we could not retrieve adequate information about the patient features and treatment types to provide an explanation for this finding.
| CONCLUSIONS
This is the first report of ENL in our country. We observed a female predominance that is different from that reported in most countries and may represent a peculiarity of some Latin American areas. In comparison with Western countries, Chile showed a significantly high prevalence of NK/T-cell nasal-type lymphoma, while the frequency of B-cell ENL and their anatomic distribution appeared similar, being GI tract the most commonly involved site.
FIGURE 3
Overall survival of the most common extranodal lymphomas subtypes. CNS, central nervous system; GI, gastrointestinal
